Selective remodeling of ABC transporter expression in drug-resistant high grade serous ovarian cancer

Objectives Drug resistance remains a major challenge in high-grade serous ovarian cancer (HGSOC). We characterized selected ATP-binding cassette (ABC) transporter expression patterns in carboplatin- and olaparib-resistant ovarian cancer cells and examined ABCB1 protein abundance and the effect of elacridar on olaparib response. Methods Parental and stepwise-generated resistant OVCAR-3 cells and resistant OVSAHO derivatives were studied. Drug response was assessed by the sulforhodamine B (SRB) assay, and apoptosis by Annexin V/propidium iodide (PI) flow cytometry. Eight ABC transporter genes were analyzed by quantitative real-time PCR (qPCR). ABCB1 protein was assessed by Western blotting. Olaparib response with or without elacridar and elacridar-associated ABCB1 messenger RNA (mRNA) changes were evaluated in high olaparib-resistant cells. Results Resistant OVCAR-3 populations showed reduced drug-induced growth inhibition and apoptosis. ABCB1 messenger RNA (mRNA) increased in resistant cells from both cell-line backgrounds, whereas other transporter profiles varied with drug and cell line. ABCB1 protein abundance was higher in both olaparib-resistant OVCAR-3 sublines than in parental cells, without a further increase from moderate to high resistance. In high olaparib-resistant cells, 50 µM olaparib produced 2.0 % mean growth inhibition vs. 44.5 % during co-treatment with 1.25 µM elacridar. Elacridar alone produced a smaller inhibitory response and was associated with lower ABCB1 messenger RNA. Conclusions Drug resistance was associated with gene- and model-dependent changes in the selected ABC transporters. Increased ABCB1 protein abundance and enhanced olaparib response during elacridar co-treatment support an ABCB1-associated resistant phenotype in OVCAR-3 cells, but do not establish transporter-specific causality.

Authors

Institutions

Publication Details

Journal
Turkish Journal of Biochemistry
Published
2026-11-18
DOI
https://doi.org/10.1515/tjb-2026-0094
Primary Topic
Drug Transport and Resistance Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Selective remodeling of ABC transporter expression in drug-resistant high grade serous ovarian cancer

İrem Durmaz, Elif Merve Aydın, Deren Demirel Yavuz
2 links
Turkish Journal of Biochemistry
Drug Transport and Resistance Mechanisms
article

Selective remodeling of ABC transporter expression in drug-resistant high grade serous ovarian cancer

İrem Durmaz, Elif Merve Aydın, Deren Demirel Yavuz
article en

Abstract

Objectives Drug resistance remains a major challenge in high-grade serous ovarian cancer (HGSOC). We characterized selected ATP-binding cassette (ABC) transporter expression patterns in carboplatin- and olaparib-resistant ovarian cancer cells and examined ABCB1 protein abundance and the effect of elacridar on olaparib response. Methods Parental and stepwise-generated resistant OVCAR-3 cells and resistant OVSAHO derivatives were studied. Drug response was assessed by the sulforhodamine B (SRB) assay, and apoptosis by Annexin V/propidium iodide (PI) flow cytometry. Eight ABC transporter genes were analyzed by quantitative real-time PCR (qPCR). ABCB1 protein was assessed by Western blotting. Olaparib response with or without elacridar and elacridar-associated ABCB1 messenger RNA (mRNA) changes were evaluated in high olaparib-resistant cells. Results Resistant OVCAR-3 populations showed reduced drug-induced growth inhibition and apoptosis. ABCB1 messenger RNA (mRNA) increased in resistant cells from both cell-line backgrounds, whereas other transporter profiles varied with drug and cell line. ABCB1 protein abundance was higher in both olaparib-resistant OVCAR-3 sublines than in parental cells, without a further increase from moderate to high resistance. In high olaparib-resistant cells, 50 µM olaparib produced 2.0 % mean growth inhibition vs. 44.5 % during co-treatment with 1.25 µM elacridar. Elacridar alone produced a smaller inhibitory response and was associated with lower ABCB1 messenger RNA. Conclusions Drug resistance was associated with gene- and model-dependent changes in the selected ABC transporters. Increased ABCB1 protein abundance and enhanced olaparib response during elacridar co-treatment support an ABCB1-associated resistant phenotype in OVCAR-3 cells, but do not establish transporter-specific causality.

Turkish Journal of Biochemistry
Koç University (TR), Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (TR)
Good health and well-being
Drug Transport and Resistance Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon